{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:53:44Z","timestamp":1785423224086,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-025-00725-9","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:09:46Z","timestamp":1746184186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The risk factors of liver cirrhosis complicated with portal vein thrombosis and the efficacy and safety of anticoagulant therapy: a meta analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Le","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Chun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"725_CR1","doi-asserted-by":"publisher","unstructured":"Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis. 2021 Apr;22(4):176\u2013186. https:\/\/doi.org\/10.1111\/1751-2980.12970. Epub 2021 Mar 7. Erratum in: J Dig Dis. 2021 May;22(5):295.","DOI":"10.1111\/1751-2980.12970"},{"key":"725_CR2","doi-asserted-by":"publisher","unstructured":"Ju C, Li X, Gadani S, Kapoor B, Partovi S. Portal Vein Thrombosis: Diagnosis and Endovascular Management. Rofo. 2022 Feb;194(2):169\u2013180. English. https:\/\/doi.org\/10.1055\/a-1642-0990. Epub 2021 Oct 14.","DOI":"10.1055\/a-1642-0990"},{"issue":"8","key":"725_CR3","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/liv.14121","volume":"39","author":"C Noronha Ferreira","year":"2019","unstructured":"Noronha Ferreira C, Marinho RT, Cortez-Pinto H, Ferreira P, Dias MS, Vasconcelos M, Alexandrino P, Serejo F, Pedro AJ, Gon\u00e7alves A, Palma S, Leite I, Reis D, Dami\u00e3o F, Valente A, Xavier Brito L, Baldaia C, Fatela N, Ramalho F, Velosa J. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study. Liver Int. 2019Aug;39(8):1459\u201367. https:\/\/doi.org\/10.1111\/liv.14121. (Epub 2019 May 15).","journal-title":"Liver Int"},{"issue":"6","key":"725_CR4","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","volume":"156","author":"NM Intagliata","year":"2019","unstructured":"Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology. 2019May;156(6):1582-1599.e1. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.265. (Epub 2019 Feb 13).","journal-title":"Gastroenterology"},{"key":"725_CR5","doi-asserted-by":"publisher","unstructured":"Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012 Jul;32(6):919\u201327. https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02785.x. Epub 2012 Mar 21.","DOI":"10.1111\/j.1478-3231.2012.02785.x"},{"key":"725_CR6","doi-asserted-by":"publisher","unstructured":"Zhang Donglei, Yang Ning. Risk factors related to portal vein thrombosis in cirrhotic patients. International Journal of Chinese Digestion,2008,16(27): 30106\u20133109. (in Chinese) https:\/\/doi.org\/10.3969\/j.issn.1009-3079.2008.27.018.","DOI":"10.3969\/j.issn.1009-3079.2008.27.018"},{"key":"725_CR7","unstructured":"Lin Guoshuai, Xu Qin, Zhao Shuyi, et al. Analysis of clinical features and related risk factors of liver cirrhosis complicated with portal vein thrombosis. The Chinese journal of liver disease, 2016, 24 (7) : 513\u2013517. The 10.3760 \/ cma. J.i SSN. 1007\u20133418.2016.07.006."},{"key":"725_CR8","doi-asserted-by":"publisher","unstructured":"Zhao Huaying, Li Yunze, Wei Tianling, et al. Analysis of risk factors for liver cirrhosis complicated with portal vein thrombosis. Medical Information,2019,32(3):86\u201388,92. https:\/\/doi.org\/10.3969\/j.issn.1006-1959.2019.03.026.","DOI":"10.3969\/j.issn.1006-1959.2019.03.026"},{"key":"725_CR9","doi-asserted-by":"publisher","unstructured":"Lv Jing, Dong Sisi, GU Hongtu, et al. Risk factors and TCM syndromic characteristics of portal vein thrombosis in cirrhosis. Journal of Clinical Hepatobiliary Diseases,2019,35(10):2210\u20132213.https:\/\/doi.org\/10.3969\/j.issn.1001-5256.2019.10.016.","DOI":"10.3969\/j.issn.1001-5256.2019.10.016"},{"key":"725_CR10","doi-asserted-by":"publisher","unstructured":"Xiong Jingping, LIU Haiying, ZHANG Yuexin. Analysis of risk factors associated with portal vein thrombosis in cirrhosis. Liver,2018,23(3):206\u2013209. https:\/\/doi.org\/10.3969\/j.issn.1008-1704.2018.03.007.","DOI":"10.3969\/j.issn.1008-1704.2018.03.007"},{"key":"725_CR11","unstructured":"Zhou Lei, Kong derun. Risk factors of liver cirrhosis complicated with portal vein thrombosis. Journal of Anhui Medical University,2014(10):1505\u20131507."},{"key":"725_CR12","doi-asserted-by":"publisher","unstructured":"Zhou Qingnan, Zhang Guo, Nongbing, et al. Analysis of risk factors for portal vein thrombosis in patients with liver cirrhosis. Chinese Journal of Clinical Oncology, 2019,14(4):360\u2013363. (in Chinese) https:\/\/doi.org\/10.3969\/j.issn.1674-3806.2021.04.07.","DOI":"10.3969\/j.issn.1674-3806.2021.04.07"},{"key":"725_CR13","doi-asserted-by":"publisher","unstructured":"Yang Qiyuan, Luo Duo, Shen Bo, et al. Analysis of risk factors for portal vein thrombosis in cirrhosis. Journal of Guangzhou Medical University,2017,45(5):18\u201321. (in Chinese) https:\/\/doi.org\/10.3969\/j.issn.2095-9664.2017.05.05.","DOI":"10.3969\/j.issn.2095-9664.2017.05.05"},{"key":"725_CR14","unstructured":"Jiang Xuan, LIU Yulan, JIN Penghua, et al. Clinical analysis of portal vein thrombosis in liver cirrhosis. Chinese Journal of Digestion, 2004,24 (06):329\u2013331."},{"key":"725_CR15","unstructured":"Tian Ying, Chen Wenming, Zhang Donglei, et al. The multi-factor analysis of portal vein thrombosis in patients with cirrhosis. Chinese journal of refresher doctors, 2012, 35 (22) : 21\u201324. The 10.3760 \/ cma. J.i SSN. 1673\u20134904.2012.22.007."},{"key":"725_CR16","doi-asserted-by":"publisher","unstructured":"Wang Yuanyuan, Wu Zigang, Du Yiping, et al. Clinical features of liver cirrhosis complicated with portal vein thrombosis. International Journal of Digestive Diseases,2011,31(4):239\u2013242. (in Chinese) https:\/\/doi.org\/10.3969\/j.issn.1673-534X.2011.04.016.","DOI":"10.3969\/j.issn.1673-534X.2011.04.016"},{"key":"725_CR17","doi-asserted-by":"publisher","unstructured":"Zhang Yue, Don Wenhua, Ma Zushuai. Analysis of risk factors and short-term prognosis of PVT in liver cirrhosis. Journal of Modern Integrated Chinese and Western Medicine,2018,27(6):612\u2013614. (in Chinese) https:\/\/doi.org\/10.3969\/j.issn.1008-8849.2018.06.012.","DOI":"10.3969\/j.issn.1008-8849.2018.06.012"},{"issue":"24","key":"725_CR18","first-page":"32","volume":"36","author":"Z Qi","year":"2015","unstructured":"Qi Z, Lianyi G. Analysis of risk factors for portal vein thrombosis in liver cirrhosis. Medicine and Philosophy. 2015;36(24):32\u20134 ((in Chinese)).","journal-title":"Medicine and Philosophy"},{"key":"725_CR19","doi-asserted-by":"publisher","unstructured":"Sun Shulun, Wang Xiaoyan. Risk factors and prognostic methods of liver cirrhosis complicated with portal vein thrombosis. Journal of Clinical Medical Literature Electronic,2018,5(34):81,83. (in Chinese) https:\/\/doi.org\/10.3877\/j.issn.2095-8242.2018.34.041.","DOI":"10.3877\/j.issn.2095-8242.2018.34.041"},{"key":"725_CR20","doi-asserted-by":"publisher","unstructured":"Chi Tian-Yu, Zhang Mei. Analysis of risk factors for venous thrombosis in cirrhosis. Journal of Gastroenterology and Hepatology,2017,26(1):17\u201319. (in Chinese) https:\/\/doi.org\/10.3969\/j.issn.1006-5709.2017.01.005.","DOI":"10.3969\/j.issn.1006-5709.2017.01.005"},{"issue":"9","key":"725_CR21","first-page":"1231","volume":"25","author":"M Yong","year":"2020","unstructured":"Yong M, Zhilin Z, Xuhui Y, et al. Effect of P-selectin and D-dimer on early prediction of portal vein thrombosis in liver cirrhosis. Modern Digestion and Interventional Therapy. 2020;25(9):1231\u20134.","journal-title":"Modern Digestion and Interventional Therapy"},{"issue":"2","key":"725_CR22","first-page":"280","volume":"51","author":"Hu Liu Jinzhi","year":"2016","unstructured":"Liu Jinzhi Hu, Jianming NX. Risk factors and prognosis of liver cirrhosis complicated with portal vein thrombosis. Journal of Anhui Medical University. 2016;51(2):280\u20133 ((in Chinese)).","journal-title":"Journal of Anhui Medical University"},{"issue":"11","key":"725_CR23","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/hepr.13942","volume":"53","author":"A Sato","year":"2023","unstructured":"Sato A, Watanabe S, Iseki M, Yamada Y, Kobayashi R, Furuya M, Arai K, Ohshina E, Tashiro Y, Nozaka T, Matsuoka M, Yauchi M, Kobayashi K, Matsumoto T, Furumoto Y, Asano T, Azuma S. Anticoagulation against portal vein thrombosis reduces mortality and liver cirrhosis-related complications: A propensity score-matched study. Hepatol Res. 2023Nov;53(11):1096\u2013104. https:\/\/doi.org\/10.1111\/hepr.13942. (Epub 2023 Jul 22).","journal-title":"Hepatol Res"},{"issue":"13\u201314","key":"725_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00508-018-1351-y","volume":"130","author":"B Scheiner","year":"2018","unstructured":"Scheiner B, Stammet PR, Pokorny S, Bucsics T, Schwabl P, Brichta A, Thaler J, Lampichler K, Ba-Ssalamah A, Ay C, Ferlitsch A, Trauner M, Mandorfer M, Reiberger T. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function. Wien Klin Wochenschr. 2018Jul;130(13\u201314):446\u201355. https:\/\/doi.org\/10.1007\/s00508-018-1351-y. (Epub 2018 Jun 18).","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"725_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","volume":"28","author":"H Chen","year":"2016","unstructured":"Chen H, Liu L, Qi X, He C, Wu F, Fan D, Han G. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2016Jan;28(1):82\u20139. https:\/\/doi.org\/10.1097\/MEG.0000000000000482.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"725_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3350\/cmh.2014.20.4.384","volume":"20","author":"JW Chung","year":"2014","unstructured":"Chung JW, Kim GH, Lee JH, Ok KS, Jang ES, Jeong SH, Kim JW. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Clin Mol Hepatol. 2014Dec;20(4):384\u201391. https:\/\/doi.org\/10.3350\/cmh.2014.20.4.384. (Epub 2014 Dec 24).","journal-title":"Clin Mol Hepatol"},{"issue":"10","key":"725_CR27","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1007\/s10620-020-06695-4","volume":"66","author":"L Naymagon","year":"2021","unstructured":"Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Mascarenhas J, Schiano T. Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis. Dig Dis Sci. 2021Oct;66(10):3619\u201329. https:\/\/doi.org\/10.1007\/s10620-020-06695-4. (Epub 2020 Nov 5).","journal-title":"Dig Dis Sci"},{"issue":"3","key":"725_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.15403\/jgld-3392","volume":"30","author":"MM Florescu","year":"2021","unstructured":"Florescu MM, Costache A, Iacob SM, Pietrareanu C, Ester C, Cerban R, Dumitru R, Grasu M, Lupescu I, Gheorghe L. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience. J Gastrointestin Liver Dis. 2021Sep 21;30(3):374\u20139. https:\/\/doi.org\/10.15403\/jgld-3392.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"10","key":"725_CR29","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/MEG.0000000000001846","volume":"32","author":"MH Ai","year":"2020","unstructured":"Ai MH, Dong WG, Tan XP, Xu L, Xu C, Zhang Q, Zhang Y, Li J. Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2020Oct;32(10):1395\u2013400. https:\/\/doi.org\/10.1097\/MEG.0000000000001846.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"725_CR30","doi-asserted-by":"publisher","unstructured":"Lu S, Chen J, Zhang R, Luo T, Ma L, Xu P, Ding H, Zeng X, Wu B, Shi Y, Liu C, Mu Y, Chen S, Wang J. Comparative effectiveness of warfarin in cirrhotic patients with non-symptomatic portal vein thrombosis: a multicenter, randomized controlled trial. Expert Rev Gastroenterol Hepatol. 2024 Jan-Feb;18(1\u20133):5\u201312. https:\/\/doi.org\/10.1080\/17474124.2024.2307575. Epub 2024 Jan 29.","DOI":"10.1080\/17474124.2024.2307575"},{"issue":"1","key":"725_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12959-023-00454-x","volume":"21","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhao Y, Li D, Guo M, Li H, Liu R, Cui X. Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study. Thromb J. 2023Jan 30;21(1):13. https:\/\/doi.org\/10.1186\/s12959-023-00454-x.","journal-title":"Thromb J"},{"issue":"1","key":"725_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12876-024-03322-8","volume":"24","author":"Y Shi","year":"2024","unstructured":"Shi Y, Feng W, Cai J, Wang Z, Pu Y, Mao W, Zhan K, Chen D. Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study. BMC Gastroenterol. 2024Jul 13;24(1):224. https:\/\/doi.org\/10.1186\/s12876-024-03322-8.","journal-title":"BMC Gastroenterol"},{"key":"725_CR33","doi-asserted-by":"publisher","unstructured":"Cheloff AZ, Bonanni LJ, Kirschenbaum JD, Luke N, Engelman JL, Ross JL, Fuligni G, Northup PG. Treatment of portal vein thrombosis in cirrhosis is associated with no survival advantage: a retrospective controlled study. Hepatol Int. 2024 Oct 1. https:\/\/doi.org\/10.1007\/s12072-024-10734-x. Epub ahead of print.","DOI":"10.1007\/s12072-024-10734-x"},{"key":"725_CR34","doi-asserted-by":"publisher","unstructured":"Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With andWithoutCirrhosis.Gastroenterology.2019May;156(6):1582\u20131599.e1.https:\/\/doi.org\/10.1053\/j.gastro.2019.01.265. Epub 2019 Feb 13.","DOI":"10.1053\/j.gastro.2019.01.265"},{"issue":"22","key":"725_CR35","doi-asserted-by":"publisher","first-page":"6769","DOI":"10.3748\/wjg.v21.i22.6769","volume":"21","author":"DJ Harding","year":"2015","unstructured":"Harding DJ, Perera MT, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol. 2015Jun 14;21(22):6769\u201384. https:\/\/doi.org\/10.3748\/wjg.v21.i22.6769.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"725_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.14744\/hf.2022.2022.0005","volume":"3","author":"C Ak","year":"2022","unstructured":"Ak C, Adali G, Sayar S, Agackiran A, Kulali F, Kahraman R, Ozturk O, Ozdil K. Portal vein thrombosis risk factors in liver transplant candidates. Hepatol Forum. 2022Sep 23;3(3):88\u201392. https:\/\/doi.org\/10.14744\/hf.2022.2022.0005.","journal-title":"Hepatol Forum"},{"key":"725_CR37","doi-asserted-by":"publisher","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022 Apr;76(4):959\u2013974. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022. Epub 2021 Dec 30. Erratum in: J Hepatol. 2022 Jul;77(1):271. https:\/\/doi.org\/10.1016\/j.jhep.2022.03.024.","DOI":"10.1016\/j.jhep.2021.12.022 10.1016\/j.jhep.2022.03.024"},{"issue":"2","key":"725_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-0030-1251501","volume":"36","author":"T Lisman","year":"2010","unstructured":"Lisman T, Porte RJ. The role of platelets in liver inflammation and regeneration. Semin Thromb Hemost. 2010Mar;36(2):170\u20134. https:\/\/doi.org\/10.1055\/s-0030-1251501. (Epub 2010 Apr 22).","journal-title":"Semin Thromb Hemost"},{"key":"725_CR39","doi-asserted-by":"publisher","unstructured":"Basili S, Carnevale R, Nocella C, Bartimoccia S, Raparelli V, Talerico G, Stefanini L, Romiti GF, Perticone F, Corazza GR, Piscaglia F, Pietrangelo A, Violi F; PRO\u2010LIVER Collaborators. Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis. Hepatol Commun. 2019 Mar 2;3(4):504\u2013512. https:\/\/doi.org\/10.1002\/hep4.1317.","DOI":"10.1002\/hep4.1317"},{"issue":"6","key":"725_CR40","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1160\/TH05-04-0270","volume":"93","author":"G Dav\u00ec","year":"2005","unstructured":"Dav\u00ec G, Ferroni P. CD40-CD40L interactions in platelet activation. Thromb Haemost. 2005Jun;93(6):1011\u20132. https:\/\/doi.org\/10.1160\/TH05-04-0270.","journal-title":"Thromb Haemost"},{"issue":"2","key":"725_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/ATVBAHA.110.217885","volume":"31","author":"P Pignatelli","year":"2011","unstructured":"Pignatelli P, Carnevale R, Di Santo S, Bartimoccia S, Sanguigni V, Lenti L, Finocchi A, Mendolicchio L, Soresina AR, Plebani A, Violi F. Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction. Arterioscler Thromb Vasc Biol. 2011Feb;31(2):423\u201334. https:\/\/doi.org\/10.1161\/ATVBAHA.110.217885. (Epub 2010 Nov 11).","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"725_CR42","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/lt.24387","volume":"22","author":"H Chen","year":"2016","unstructured":"Chen H, Turon F, Hern\u00e1ndez-Gea V, Fuster J, Garcia-Criado A, Barrufet M, Darnell A, Fondevila C, Garcia-Valdecasas JC, Garcia-Pag\u00e1n JC. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl. 2016Mar;22(3):352\u201365. https:\/\/doi.org\/10.1002\/lt.24387.","journal-title":"Liver Transpl"},{"issue":"1","key":"725_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","volume":"115","author":"DA Simonetto","year":"2020","unstructured":"Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. Am J Gastroenterol. 2020Jan;115(1):18\u201340. https:\/\/doi.org\/10.14309\/ajg.0000000000000486.","journal-title":"Am J Gastroenterol"},{"key":"725_CR44","doi-asserted-by":"publisher","unstructured":"Yao Hongyan.Pharmacokinetics and clinical application of novel oral anticoagulants. Intl Med Rev. 2022;28(19):2809\u201312. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-1245.2022.19.032.","DOI":"10.3760\/cma.j.issn.1007-1245.2022.19.032"},{"issue":"10","key":"725_CR45","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jtha.2024.07.009","volume":"22","author":"JH Levy","year":"2024","unstructured":"Levy JH, Shaw JR, Castellucci LA, Connors JM, Douketis J, Lindhoff-Last E, Rocca B, Samama CM, Siegal D, Weitz JI. Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost. 2024Oct;22(10):2889\u201399. https:\/\/doi.org\/10.1016\/j.jtha.2024.07.009. (Epub 2024 Jul 17).","journal-title":"J Thromb Haemost"},{"issue":"3","key":"725_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2450\/2010.0149-09","volume":"8","author":"M Franchini","year":"2010","unstructured":"Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus. 2010;8(3):149\u201354. https:\/\/doi.org\/10.2450\/2010.0149-09.","journal-title":"Blood Transfus"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00725-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:10:00Z","timestamp":1746184200000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-025-00725-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00725-9","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An ethics statement is not applicable because this study is based on published literatures. Because our study is a meta-analysis,it is not necessary to get patient\u2019s consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to be published in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}